What to Expect in 2027?

Novel conjugates are where the next generation of ADC development is being decided. The first bispecific ADC has reached the market, dual-payload and alternative-mechanism programs are entering the clinic, and pharma has backed the space with deals and acquisitions across dual-payload, degrader and novel-payload platforms. Meanwhile, classical Topo1 and MMAE payloads face resistance, narrow therapeutic windows and a crowded field, pushing discovery teams to differentiate.

The 6th Novel Conjugates Summit is the only industry-led meeting built exclusively around this science. It covers the most advanced areas of novel payload and format development: dual-payload ADCs, pathway-directed payloads, degrader and oligonucleotide conjugates, bispecific and biparatopic ADCs, and peptide and fragment-based formats. Sessions focus on the questions that decide whether a program succeeds: payload pairing, PK and ratio control, target and format selection, translational models and the preclinical evidence needed for IND.

With 80+ discovery, bioconjugation and R&D leaders from big pharma, ADC- focused and novel conjugate biotechs, and a single-track agenda with no traditional ADC content, it is the one date in the ADC calendar where every presentation and conversation is about what comes next. New data is arriving faster than any single meeting can cover, which is why being in the room matters.

Across a workshop day and two conference days, you will leave with fresh data, practical frameworks for design and translation, and a network of peers working on the same problems. Download the event guide to see the full programme.

About Event - 5th Novel Conjugates Summit

Unmissable Event Highlights

Look Beyond Topo1 & MMAE

Hear how teams are designing and testing pathway-directed and alternative-mechanism payloads, to help you decide which mechanisms are worth pursuing and how to overcome resistance in your own pipeline.

Get the Latest on Dual-Payload ADCs

Explore how teams choose payload pairs and tune ratio, PK and tolerability, to help you balance efficacy against toxicity and protect the therapeutic index as you move your program toward the clinic.

Rethink Targeting with Bispecifics & Smaller Formats

Compare bispecific, biparatopic, peptide and fragment-based approaches on selectivity, tumor penetration and clearance, to help you choose the right format for your target and patient population.

Bring Your Own Challenges

Join workshops on rational design and preclinical signposts, plus an open “Burning Questions Session”, giving you the opportunity to pressure test your ideas, and resolve unanswered questions with peers before they become costly late-stage problems. 

Explore the 2026 Event Guide

  • 20 Expert Speakers from Big Pharma & Leading Novel Conjugate Biotechs
  • 8+ New Data Presentations on Dual-Payload, Pathway-Directed, Degrader & Bispecific Conjugates
  • Pre-Conference Workshops on Designing Novel Conjugates with Clinical Intent
  • Dedicated Content on Peptides, Oligonucleotides & Conjugates Beyond Oncology
  • Speed Networking, Poster Sessions & Open Q&A Built into the Program

Attending Companies Include

Explore The Agenda - 5th Novel Conjugates Summit
Explore the Agenda

Preview data-led sessions on dual-payload, pathway-directed, degrader and bispecific conjugates, and two pre-conference workshops on rational design and preclinical signposts. Download the event guide for the full agenda and speaker faculty across three days.

Partner With Us - 5th Novel Conjugates Summit
Partner With Us
Meet 80+ discovery, bioconjugation and R&D leaders who are choosing partners for dual-payload, degrader, bispecific and non-antibody programs. Extend your reach beyond the flagship ADC meetings into a room where every attendee is focused on what comes next and inquire to see the partnership options.
Conjugates Experts - 5th Novel Conjugates Summit
Join the Community
Join 80+ scientists driving novel conjugate development, from big pharma discovery teams to emerging biotechs, in a single-track meeting with time to speak with everyone in the room. Download the guide or inquire to secure your place.